MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Bayesian Re-Analysis of Phase I and II Subthalamic Nucleus Perfusion Changes Following Mesenchymal Stem Cell Infusion in Parkinson’s Disease

    T. Thomas, T. Ellmore, E. Tharp, J. Martinez-Lemus, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: To compare subthalamic nucleus (STN) perfusion changes following mesenchymal stem cell (MSC) infusion in Parkinson’s disease (PD) using Bayesian methods in both Phase I…
  • 2025 International Congress

    Impact of Patient-Specific Structural Connectivity of STN-DBS on Balance and Mobility – Pilot study

    š. Janovič, S. Holly, M. Chmelík, D. Juskanič, L. Pátrovič, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To evaluate the impact of patient-specific structural connectivity between VTA in STN targeting and SMA/preSMA on functional mobility improvements in PD patients undergoing DBS.…
  • 2025 International Congress

    The Genetic Landscape of Parkinson’s Disease in African and Admixed Populations: Discovering Population-Specific Risk and Unveiling Etiological Insights

    O. Ojo, N. Okubadejo, M. Makarious, S. Bandres-Ciga (Lagos, Nigeria)

    Objective: To perform the largest PD risk genome-wide association study (GWAS) in the African and African admixed populations. Background: Investigating the genetic foundation of Parkinson’s…
  • 2025 International Congress

    First Insights into Genetic Findings from the Mexican Parkinson’s Research Network (MEX-PD): The Case of MTHFR

    P. Reyes-Pérez, A. Lazaro-Figueroa, I. Estrada-Bellmann, Y. Matuk-Pérez, C. Guerra-Galicia, K. Salinas-Barboza, E. Morelos Figaredo, N. Gandarilla-Martínez, V. Flores-Ocampo, E. Waldo, A. Zayas-Del Moral, I. Espinosa-Méndez, M. Inca-Martinez, U. Caballero-Sánchez, T. P. Leal, I. Mata, E. Gaspar-Martínez, M. Rentería, S. Alcauter-Solorzano, A. Ruiz-Contreras, A. Medina-Rivera (Queretaro, Mexico)

    Objective: To present the first genetic findings of the MEX-PD cohort, with a specific focus on analyzing the role of MTHFR variants Background: Despite significant…
  • 2025 International Congress

    Parkinson’s disease (PD) associated with the E46K mutation in the SNCA gene, twenty years after

    B. Tijero Merino, MA. Acera Gil, I. Gabilondo, T. Fernandez Valle, M. Ruiz Lopez, R. Sanchez Pernaute, A. Murueta-Goyena, I. Diez, C. Juanes, R. Del Pino, N. Ayo-Mentxakatorre, JC. Gomez-Esteban (Barakaldo, Spain)

    Objective: To provide an updated overview of Parkinson’s disease (PD) associated with E46K mutation carriers in the SNCA gene 20 years after its description, incorporating…
  • 2025 International Congress

    A Case for Novel Phenotypes Associated with Digenic CHMP2B-LRRK2 Mutations

    D. Vijaywargiya, T. Chabrashvili (Liverpool, USA)

    Objective: We report a patient presenting with both bv-FTD & PD phenotypes, alongside a complex family history featuring multiple neurodegenerative disorders. Background: The CHMP2B &…
  • 2025 International Congress

    Building Genetic Counseling Capacity in Latin America: The PD GENEration–LARGE-PD Training Framework

    V. Caceres, R. de León, M. Inca Martinez, I F. Mata, A. Coral, P. Hodges (Indianapolis, USA)

    Objective: The PD GENEration (PD GENE) study has expanded into Latin America through collaboration with the Latin American Research Consortium on the GEnetics of Parkinson's…
  • 2025 International Congress

    Automated Image-Guided Programming Algorithm Supports Clinicians During DBS Programming for Parkinson’s Disease Patients

    J. Aldred, C. Luca, A. Ramirez-Zamora, J. Wong, K. Wessels, T. Peabody, B. Reese, B. Farber Petrey, R. Mustakos, S. Niketeghad, R. Shivacharan, M. Malekmohammadi (Valencia, USA)

    Objective: To assess clinical outcomes of an acute automated image-guided programming (aIGP) algorithm in PD patients implanted with a deep brain stimulation (DBS) system. Background:…
  • 2025 International Congress

    Optimization of Adaptive Deep Brain Stimulation Settings in Patients with Parkinson’s Disease

    K. Kimura, H. Kishida, K. Abe, N. Ueda, F. Tanaka (Yokohama, Japan)

    Objective: To evaluate the specific programming parameters of adaptive deep brain stimulation (aDBS) in Parkinson’s disease (PD) and identify the most effective settings for optimizing…
  • 2025 International Congress

    Deep Brain Stimulation in Late-Stage Parkinson’s Disease: Insights from Clinical Practice

    P. Antenucci, F. Colucci, A. Gozzi, M. Pugliatti, M. Sensi (Ferrara, Italy)

    Objective: To compare Late-stage Parkinson's disease (LSPD) patients who completed at least one year of oral medical therapy alone after IPG depletion with those who…
  • « Previous Page
  • 1
  • …
  • 77
  • 78
  • 79
  • 80
  • 81
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley